Pakistan faces a critical shortage of over 100 essential medicines, including life-saving drugs. Delayed price revisions by the Drug Regulatory Authority of Pakistan are disrupting production. Rising costs of raw materials and currency depreciation have impacted manufacturing expenses significantly. This situation is creating space for counterfeit and substandard products in the market. Industry representatives urge the government to approve pending hardship pricing cases immediately.
Related Posts
Hardik Pandya trade: CSK enter the race; seven franchises express interest
Seven IPL franchises have expressed interest in signing Hardik Pandya after the all-rounder decided to leave Mumbai Indians. Chennai Super…
Wife of retired IAF Wing Commander dies after jumping from multi-level car park in Noida
A Noida woman, identified as Situ Talwar, tragically fell from the Sector 18 multi-level car park on Saturday evening. Preliminary…